RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS

Show other versions (1)

Цель. Целями настоящей работы, в которую вошли 2 последовательных исследования в группе больных с высоким сердечно-сосудистым риском с критериями включения, аналогичными исследованию HOPE (Heart Outcomes Prevention Evaluation), были: 1) проверка гипотезы о том, что рамиприл улучшает способность тром...

Full description

Bibliographic Details
Main Authors:	S. R. Willoughby, S. Rajendran, W. P. Chan, N. Procter, S. Leslie, E. A. Liberts, T. Heresztyn, Y. Y. Chirkov, J. D. Horowitz
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-12-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:	https://www.rpcardio.com/jour/article/view/511

Similar Items

RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS
by: S. R. Willoughby, et al.
Published: (2015-12-01)

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»
by: D. V. Nebieridze
Published: (2015-12-01)

COMMENTS TO THE PAPER «RAMIPRIL SENSITAZES PLATELETS TO NITRIC OXIDE. IMPLICATION FOR THERAPY IN HIGH-RISK PATIENTS»
by: D. V. Nebieridze
Published: (2015-12-01)

Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction
by: Wolfgang Linz, et al.
Published: (2003-09-01)

Ramipril therapy in acute myocardial infarction
by: V. A. Lusov, et al.
Published: (2008-10-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION
by: I. V. Szirov, et al.
Published: (2015-12-01)

A Comparative Evaluation of Ramipril as Monotherapy and Combination of Ramipril with Torsemide in Hypertension
by: Navjot Kaur, et al.
Published: (2017-11-01)

Regulation of blood platelet function by nitric oxide
by: Wake, Jonathan D.
Published: (2013)

Comparative Efficacy and Safety of Triple Therapy (Ramipril, Telmisartan, Hydrochlorothiazide) Vs Dual Anti Hypertensive Therapy (Ramipril or Telmisartan, Hydrochlorothiazide) in Stage 2 Hypertensive Patients
by: Bharat Bhushan, et al.
Published: (2014-08-01)

Ramipril induced pemphigoid vulgaris
by: Mirza MA, et al.
Published: (2018-09-01)

S-nitrosothiols, nitric oxide and platelet and vascular dysfunction in cirrhosis
by: Ollosson, Richard Charles
Published: (2008)

Platelets in coronary artery disease and their inhibition by nitric oxide donors
by: Langford, Edward John
Published: (1996)

Endogenous nitric oxide and platelet function in in vivo models of thromboembolism
by: Emerson, Michael
Published: (1998)

Interactions among nitric oxide, prostacyclin and platelets in myocardial ischaemia
by: Aitchison, Keri Alexandria
Published: (1996)

Targeting the nitric oxide signalling pathway to modulate platelet function
by: Apostoli, Georgina Lorraine
Published: (2014)

Ramipril poisoning rescued by naloxone and terlipressin
by: Samanta Samanta, et al.
Published: (2014-01-01)

Ramipril: “Vieja” Droga, Nueva Indicación
by: Marcela Botargues, et al.
Published: (2001-05-01)

Nitric oxide dysregulation in platelets from patients with advanced Huntington disease.
by: Albino Carrizzo, et al.
Published: (2014-01-01)

The interaction of nitric oxide with reactive oxygen species in the inhibition of platelet activation
by: Sabetkar, Mojhgan
Published: (2004)

B-adrenoceptors and nitric oxide production in human vascular endothelium and platelets
by: Queen, Lindsay Rachel
Published: (2002)

FIXED COMBINATION OF RAMIPRIL AND HYDROCHLOROTHIAZIDE: TO WHOM AND WHAT FOR?
by: S. V. Nedogoda
Published: (2016-09-01)

Consumer interpretation of ramipril and clopidogrel medication risk information – implications for risk communication strategies
by: Tong V, et al.
Published: (2015-07-01)

Organoprotective Effects of Spironolactone on Top of Ramipril Therapy in a Mouse Model for Alport Syndrome
by: Diana Rubel, et al.
Published: (2021-06-01)

Lipopolysaccharide induces nitric oxide synthase expression and platelet-activating factor increases nitric oxide production in human fetal membranes in culture
by: Seyffarth Gunter, et al.
Published: (2004-06-01)

Platelet content of nitric oxide synthase 3 phosphorylated at Serine 1177 is associated with the functional response of platelets to aspirin.
by: Javier Modrego, et al.
Published: (2013-01-01)

Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rats
by: Ortiz M Clara, et al.
Published: (2004-05-01)

Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets
by: Rune Kleppe, et al.
Published: (2018-02-01)

The role of inducible nitric oxide synthase and nitric oxide in tumour cells and their response to therapy
by: Fitzpatrick, Brian
Published: (2009)

Functional implications of peroxisomal nitric oxide (NO) in plants
by: Francisco Javier Corpas, et al.
Published: (2014-03-01)

Investigation of the implications of nitric oxide on biofilm development
by: Ulfenborg, Benjamin
Published: (2008)

Nitric oxide and the resolution of inflammation: implications for atherosclerosis
by: Catherine A Shaw, et al.
Published: (2005-03-01)

Cost of nitric oxide therapy in neonates
by: Nimish V Subhedar, et al.
Published: (2020-04-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
by: A. O. Konradi, et al.
Published: (2020-04-01)

Effect of ramipril on renal function in patients with intermittent claudication
by: Simon D Hobbs, et al.
Published: (2008-04-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

THE NEW FIXED COMBINATION OF AMLODIPINE AND RAMIPRIL IN THE TREATMENT OF HYPERTENSION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Can aliskiren reduce the incidence of cough caused by ramipril?
by: Outi Saijonmaa, et al.
Published: (2008-09-01)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
by: Daniele Bosone, et al.
Published: (2016-09-01)

Untersuchungen zum myokardialen Sauerstoffradikal-Stoffwechsel am Tiermodell 30 - 36 Stunden und 6 Wochen nach Myokardinfarkt unter medikamentöser Therapie mittels Ramipril, Metoprolol und Kombinationstherapie Metoprolol/Ramipril
by: Schulz, Sabine-Susan
Published: (2005)